Investment Summary |
|
|---|---|
| Date | 2022-02-24 |
| Target | Juno Pharma Canada |
| Sector | Life Science |
| Investor(s) | Signet Healthcare Partners |
| Deal Type | Growth Capital |
| Advisor(s) | Aird & Berlis (Legal) |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1998 |
| PE ASSETS | 600M USD |
| Size | Middle-Market |
| Type | Sector Focused |
Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 13 of 17 |
| Sector: Life Science M&A | 11 of 14 |
| Type: Growth Capital M&A Deals | 7 of 11 |
| State: Quebec M&A | 2 of 2 |
| Country: Canada M&A | 2 of 2 |
| Year: 2022 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-01 |
Pharma Nobis
Texarkana, Texas, United States Pharma Nobis is a developer and manufacturer of innovative pharmaceuticals and over-the-counter (OTC) medicines. Pharma Nobis is based in Texarkana, Texas. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-10-24 |
Laxai
Hyderabad, India Laxai offers contract research, development, and manufacturing solutions to pharmaceutical and specialty chemical companies globally. Laxai has collaborated with pharmaceutical companies across the value chain and partnered on multiple medicinal chemistry, integrated drug discovery, CMC Programs, and scale-up of custom-made specialty fine chemicals. Laxai is based in Hyderabad, Telangana. |
Buy | - |
